Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Despoina M. Galetaki"'
Autor:
Molly Hayes, Craig L.K. Boge, Anna Sharova, Daniel Vader, Marina Mitrou, Despoina M. Galetaki, Yun Li, Kevin J. Downes
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES. 22(12)
Prophylaxis with valganciclovir (VGCV) is used routinely to prevent cytomegalovirus (CMV) infections in at-risk pediatric solid organ transplant (SOT) recipients. However, the rate and factors associated with toxicities in this population are not wel
Autor:
Kevin J. Downes, Anna Sharova, Craig L. K. Boge, Daniel Vader, Marina Mitrou, Molly Hayes, Despoina M. Galetaki, Lauren Gianchetti, Laura A. Vella, Yun Li
Publikováno v:
Pediatric Transplantation. 26
Cytomegalovirus (CMV) is an important cause of morbidity and mortality in pediatric solid organ transplant (SOT) recipients. However, the impact of asymptomatic CMV infections (ie, DNAemia) on clinical outcomes is not well established.We performed a
Autor:
Brian T. Fisher, Despoina M Galetaki, Caitlin W Elgarten, Jason L. Freedman, Craig L K Boge, Alexander M. Newman, Molly Hayes, Timothy S. Olson
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 10(9)
Background Cytomegalovirus (CMV) is a significant source of morbidity and mortality among transplant recipients; the epidemiology is less understood in pediatric hematopoietic cell transplantation (HCT) cohorts. Furthermore, there is a paucity of dat
Autor:
Dale R. Purdy, Despoina M Galetaki, Richard L. Hodinka, Adriana E. Kajon, Brian T. Fisher, Ana María Cárdenas, Craig L K Boge, Hans Petersen, Alix E. Seif
Publikováno v:
Pediatr Transplant
Information about human adenovirus (HAdV) infection in solid organ transplant (SOT) recipients is limited. We aimed to describe HAdV infection epidemiology and outcomes in a single-center retrospective cohort during the era of polymerase chain reacti
Autor:
Laura A. Vella, Despoina M Galetaki, Molly Hayes, Kevin J. Downes, Lauren Gianchetti, Anna Sharova, Marina Mitrou, Yun Li
Publikováno v:
Open Forum Infectious Diseases
Background Ganciclovir (GCV) and valganciclovir (VGCV) are used for prophylaxis (PPX) and treatment for CMV in pediatric solid organ transplant (SOT) recipients, but the frequency and impact of toxicities from these medications are not well described
Autor:
Caitlin W Elgarten, Timothy S. Olson, Despoina M Galetaki, Jason L. Freedman, Brian T. Fisher, Craig L K Boge, Molly Hayes, Alexander M. Newman
Publikováno v:
Open Forum Infectious Diseases
Background Data on cytomegalovirus (CMV) infection and disease by donor (D)/recipient (R) status or prophylaxis regimen in pediatric hematopoietic cell transplant (HCT) recipients are limited. There is an absence of data on adverse events (AE) attrib
Autor:
Hans Petersen, Craig L K Boge, Adriana E. Kajon, Jesse Blumenstock, Sydney G Shuster, Brian T. Fisher, Despoina M Galetaki, Ana Maria Cardenas, Alix E. Seif
Publikováno v:
Open Forum Infectious Diseases
Background Human adenovirus (HAdV) is a documented source of morbidity and mortality after hematopoietic cell transplant (HCT); however, there are limited data documenting HAdV species and type in this population. Understanding the molecular characte
Autor:
Anna Sharova, Despoina M Galetaki, Molly Hayes, Lauren Gianchetti, Laura A Vella, Kevin J Downes
Publikováno v:
Open Forum Infectious Diseases
Background Our institution provides universal CMV prophylaxis (PPX) for all high (D+/R-) and medium risk (R+) solid-organ transplant (SOT) recipients. We sought to evaluate this practice by assessing CMV infection and disease within the first year of